Collectively, a higher infiltration of immunosuppressive cells and elevated immunosuppressive biomarkers contribute to the immune escape in gliomas, by inactivating tumor killing cells such as CD8+ T cells. This evidence concerns the gene CD8A and central nervous system cancer.